Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)

ClinicalTrials.gov ID: NCT05683249

Public ClinicalTrials.gov record NCT05683249. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder

Study identification

NCT ID
NCT05683249
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Neurocentria, Inc.
Industry
Enrollment
223 participants

Conditions and interventions

Conditions

Interventions

  • NRCT-101-SR Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 24, 2023
Primary completion
Jan 16, 2024
Completion
Jan 16, 2024
Last update posted
Jun 2, 2025

2023 – 2024

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Collaborative Neuroscience Network Garden Grove California 92845
Accel Research Sites Lakeland Florida 33803
Accel Research Sites Maitland Florida 32751
Miami Dade Medical Research Institute Miami Florida 33176
Velocity Clinical Research - Meridian Meridian Idaho 82642
Alcanza Clinical Research Company Boston Massachusetts 02131
Center for Psychiatry and Behavioral Medicine Las Vegas Nevada 89128
Hassman Research Institute Berlin New Jersey 08009
Coastal Carolina Research Center - North Charleston North Charleston South Carolina 29405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05683249, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 2, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05683249 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →